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Abstract
Introduction Pelvic lymph node dissection (PLND) at the
time of radical cystectomy for urothelial carcinoma of the blad-
der is critical for accurate staging and may improve oncologic
outcomes. Minimally invasive approaches have been criticized
for limiting the extent of the PLND. We reviewed our experi-
ence with PLND and its perioperative outcomes with robot-
assisted laparoscopic radical cystectomy (RARC).
Methods Data were collected prospectively from 50
patients scheduled for RARC. Included in the analysis were
patients who had RARC and a standard PLND. The entire
extirpative portion of the procedure was performed using the
da Vinci Robot (Intuitive Surgical, Sunnyvale, CA, USA).
Results A total of 41 patients were included in the study:
30 men and 11 women with a mean age of 69.7 years
(range 49–85) and a mean body mass index of 26.9 (range
19.5–43.7). The median total operative time was
497.77 min (320–805). The mean estimated blood loss was
253.66 ml (range 50–700). The transfusion rate was 44%
(18 out of 41) ranging from 0 to 4 units (median 0 units of
blood). The mean total number of lymph nodes retrieved
was 25.07 (range 4–68). Nodal metastases were seen in
14.63% (6/41). Rate of positive surgical margin was 4.87%
(2/41). The median length of hospital stay was 8 days
(5–37). The median duration of nasogastric tube, time to
ambulation, Wrst clear liquid intake, passage of colonic gas,
time to bowel movement, and start of solid food intake
were 1 (0–5), 2 (1–7), 3 (2–10), 4 (1–6), 5 (2–11) and
6 days (3–24), respectively.
Conclusion An adequate PLND, comparable with that
recommended for open surgery, can be performed safely
with robot assistance. The perioperative outcomes were
likewise comparable with that of the gold standard, open
cystectomy.
Keywords Robotic · Cystectomy · Minimally invasive · 
Lymphadenectomy · Laparoscopic
Abbreviations
PNLD Pelvic lymph node dissection
RARC Robot-assisted laparoscopic radical cystectomy
BMI Body mass index
ASA American Society of Anesthesiologists
Introduction
The American Cancer Society estimates that in 2007 there
will have been 67,160 new cases of bladder cancer diag-
nosed in the USA and 13,750 deaths from this cancer [1].
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8 J Robotic Surg (2009) 3:7–12While the majority of patients with bladder cancer present
with superWcial bladder tumors, about 20–40% will present
with, or will progress to, muscle-invasive disease. Invasive
disease is the potentially lethal form of bladder cancer and,
if left untreated, more than 85% of patients will die from
the disease within two years of diagnosis [2]. Despite an
early and aggressive surgical approach toward high-grade,
invasive bladder cancer, as many as 25% of patients are
expected to have pathologic evidence of lymph node metas-
tases at cystectomy [3]. Open radical cystectomy with stan-
dard bilateral pelvic iliac lymphadenectomy remains the
gold standard treatment for high-grade, muscle-invasive
bladder cancer [4–10].
Less invasive approaches to the surgical management of
many urologic cancers have been shown to oVer consider-
able beneWts in terms of speed of recovery, blood loss, post-
operative pain, and cosmetic results in the treatment of
urologic malignancies [11–14]. There have now been sev-
eral trials, albeit small and nonrandomized, that have
shown a beneWt for robotic cystectomy compared with open
cystectomy with regard to less blood loss and short-term
morbidity [15, 16]. Because robotic cystectomy is a rela-
tively new procedure, long-term oncologic eYcacy remains
to be determined. Several studies have demonstrated that
the quality of surgery for radical cystectomy aVects cancer
control and overall survival [17, 18]. One of the most
important surgical factors is the extent of the lymphadenec-
tomy [19]. For robotic radical cystectomy to be a viable
procedure, it is essential that this “less invasive” procedure
replicates the technical aspects of standard open proce-
dures, for example PLND. The performance of an adequate
pelvic lymph node dissection (PLND) has been regarded as
one of the most signiWcant challenges in replicating the
open technique during robot-assisted radical cystectomy
[20]. Here, we review our experience with robotic PLND
and its perioperative outcomes as performed in conjunction
with robot-assisted laparoscopic radical cystectomy
(RARC) and compared these outcomes with existing surgi-
cal guidelines.
Materials and methods
Between September 2004 and May 2008, data were col-
lected prospectively on 50 consecutive patients scheduled
for robot-assisted cystectomy. Forty-one patients under-
went a formal robotic PLND in conjunction with RARC.
Excluded from the analysis were patients that had inability
to tolerate pneumoperitoneum (n = 1), presence of grossly
enlarged pelvic lymph node (n = 3), and limited PLND
because of age and co-morbid conditions (n = 5).
The data collection protocol was approved by the
University of California, Irvine Institutional Review Board.
Surgeries were performed by a single fellowship-trained,
urologic oncologist, who had previously performed 110
robot-assisted laparoscopic radical prostatectomies prior to
performing the initial robotic cystectomy in September
2004. The da Vinci S system was introduced in March 29,
2007 which slightly modiWed the technique in that the ports
were all placed 2 cm higher than for the standard system.
This facilitated completion of the upper extent of the lymph
node dissection. Patient data analyzed were gender, age,
body mass index, length of hospital stay, operative time,
console time, estimated blood loss, blood transfusion rate,
total number of lymph nodes harvested, rate of positive
lymph nodes, rate of positive surgical margin, perioperative
and immediate postoperative complications, length of hos-
pital stay, duration of nasogastric tube, time to ambulation,
time to Wrst passage of Xatus, time to Wrst clear liquid
intake, time to Wrst bowel movement, and time to Wrst solid
intake.
Technique
All patient were prepared with a standard mechanical and
antibiotic bowel regimen preoperatively and standard peri-
operative intravenous antibiotics. After induction of general
anesthesia, patients were positioned in steep Trendelenberg
with arms tucked and legs abducted and lowered on
spreader bars to facilitate docking of the robot. A nasogas-
tric tube was placed and an 18 French foley catheter was
inserted on the sterile surgical Weld. The procedure was
approached intraperitoneally following insuZation of the
abdomen with carbon dioxide obtained using a Veress nee-
dle. The six-port conWguration has been described previ-
ously [21, 22]. A 12 mm trocar for the camera was placed
above the umbilicus. Two 8-mm ports for the robot arms
were placed just lateral to the medial umbilical ligaments.
A lateral 10/12-mm port on the right and an 8-mm robotic
port were placed medial and superior to the anterior supe-
rior iliac spine. A 5-mm port was placed in the upper right
quadrant for the suction/irrigator instrument. The camera
port was placed 24–25 cm from the symphysis pubis and
the two robotic ports were placed 18–20 cm from the sym-
physis pubis. The third robotic port was placed in the
anterior axillary line on the left side about the level of the
umbilicus (Fig. 1). Similar port placement has been
described by Hafron et al. [23]. PLND was performed
either before or after completion of radical cystectomy. In
these patients a standard lymph node dissection was per-
formed in which the genitofemoral nerve was the lateral
border, the obturator nerve was the posterior border, the
bladder was the medial border, and the internal inguinal
ring was the distal border. Proximally the dissection was
carried above the hypogastric artery, typically 2 cm below123
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tion of the aorta. Lymph nodes were typically collected as
external iliac and obturator node packets on each side.
Occasionally specimens were broken into common iliac,
external iliac, and internal iliac. Occasionally presacral
nodes were included.
Results
Forty-one patients were included in the study, 30 men and
11 women with a mean age of 69.7 years (range 49–85) and
a mean body mass index of 26.9 (range 19.5–43.7)).
Twenty-six patients had an American Society of Anesthesi-
ologists (ASA) score of III, and 14 and 1 patients were clas-
siWed as ASA II and IV, respectively. An ileal conduit or a
continent urinary diversion was performed in 24 and 17
patients, respectively. The mean total operative time was
497.77 min (320–805) with a mean robotic console time of
267.32 min (range 200–387). The time to complete the
PLND was approximately 90 min. The mean estimated
blood loss was 253.66 ml (range 50–700). The transfusion
rate was 44% (18 out of 41) with a range of 0–4 units
(median 0 units). The median total number of lymph nodes
retrieved was 23 (range 4–68). Lymph nodes were typically
collected as external iliac and obturator node packets on
each side. Occasionally specimens were broken into com-
mon iliac, external iliac, and internal iliac. Occasionally
presacral nodes were included. Nodal metastases were seen
in 14.63% (6/41). Rate of positive surgical margin was
4.87% (2/41). The ratio of positive lymph nodes to the
number harvested for the six patients with positive lymph
nodes were 4/44, 19/47, 4/14, 1/28, 1/43, and 3/23, respec-
tively. The rate of positive surgical margin was 4.87% (2/41)
and both patients had stage pT4 disease on Wnal pathology
report. The extirpative portion of all the procedures was
completed entirely intracorporeally. There were no conver-
sions to open during the entire extirpative procedure. Intra-
operative complications occurred in two patients and both
were partial transections of the obturator nerve. These were
repaired with interrupted 5–0 prolene sutures and the
patients recovered without clinical sequelae. During lym-
phadenectomy one patient had abulsion of a branch of the
common iliac vein, this was controlled robotically without
signiWcant blood loss. Perioperative complications related
to the lymphadenectomy were seen in three patients: clini-
cally signiWcant lymphocele (1) and deep vein thrombosis
(2). Other perioperative complications included ileus (4)
and bowel obstruction requiring exploratory laparotomy
and bowel resection (1). Three patients developed uretero-
enteric stricture and one patient had bladder neck contrac-
ture. The median length of hospital stay was 8 days (5–37).
The median duration of nasogastric tube, time to ambula-
tion, Wrst clear liquid intake, passage of colonic gas, time to
bowel movement and start of solid food intake were 1 (0–5),
2 (1–7), 3 (2–10), 4 (1–6), 5 (2–11), and 6 days (3–24),
respectively. A comparison of the RARC patients’ demo-
graphics and outcomes (n = 22) using the conventional da
Vinci system compared with the da Vinci S system showed
similar demographic and perioperative outcomes (P > 0.05).
However, the entire extirpative time (console time) was
reduced (P = 0.005) using the da Vinci S system.
Discussion
Open radical cystectomy with bilateral pelvic iliac lym-
phadenectomy remains the gold standard treatment for
high-grade, muscle-invasive bladder cancer, because its
beneWts have been demonstrated by large clinical series
with long follow up [4–10]. Stein and Skinner [5] showed
that the pathological stage of the primary tumor and the
presence of regional lymph node metastases were the most
important determinants of survival in patients undergoing
radical cystectomy for bladder cancer. The recurrence-free
and overall survival for the entire 1,054 patients was 68%
at 5 years and 66% at 10 years, with most deaths occurring
within the Wrst 3 years following radical cystectomy sec-
ondary to bladder cancer recurrences. For lymph node-
negative, organ-conWned disease (p · pT2b) 5-year and
10-year recurrence-free rates were 85 and 82%, respec-
tively. Herr et al. [10] showed that a thorough PLND,
which increased the number of lymph nodes removed,
aVects bladder cancer outcomes. The Wve-year survival rate
for patients with fewer than ten nodes retrieved was 44%
compared with 61% for patients with more than ten nodes
examined [6]. The introduction of laparoscopy has
Fig. 1 Port placement during robot-assisted radical cystectomy with
pelvic lymph node dissection. Symphysis pubis (P); camera port (C);
10/12 mm assistant port (12); robotic port (8); suction/irrigation port
(5). Distance from camera to symphysis pubis is 24–25 cm; distance
from robotic port to symphysis pubis is 18–20 cm123
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the management of urologic cancers, and laparoscopic pro-
cedures have become, to some, the preferred approach to
radical nephrectomy for most patients [24]. The application
of laparoscopy to radical cystectomy has been far more lim-
ited. Parra et al. [25] reported the Wrst laparoscopic simple
cystectomy for pyocystis 15 years ago, and Sanchez et al.
[26] reported the Wrst laparoscopic cystectomy for bladder
cancer with extracorporeal construction of an ileal conduit.
The feasibility of completely intracorporeal urinary diver-
sion was later shown by Gill et al. [27].
The potential beneWts of the minimally invasive laparo-
scopic approaches include reduced length of hospital stay,
reduced intraoperative blood loss, and shorter convales-
cence. We had a low threshold for transfusion in this report,
because many of the patients had preoperative anemia, in
addition to advanced age and multiple co-morbidities.
Although the oncologic eYcacy of RARC remains to be
proven in larger studies, pathologic and short-term out-
comes suggest that results are likely to be comparable with
those of contemporary open radical cystectomy [28].
Although the feasibility of laparoscopic cystectomy has
been demonstrated, its widespread acceptance has been
limited because of the technical challenges associated with
this procedure. The introduction of a robotic interface has
dramatically expanded the application of minimally inva-
sive surgery for radical prostatectomy [29] and it is likely to
have the same impact on radical cystectomy. Initial series
by Menon et al. [30] and Guru et al. [31] showed the feasi-
bility of robot-assisted radical cystectomy in three and
seven female patients, respectively. Recently, Guru et al.
[32] showed that performance of RARC can be safely con-
sidered for patients that are candidates for open cystectomy.
Robot-assisted surgery (da Vinci Surgical System, Intuitive
Surgical, Sunnyvale, CA, USA) oVers potential advantages
over traditional surgical approaches by providing excellent
three-dimensional vision, articulating instruments, ergo-
nomic design, and tenfold magniWcation of the surgical
Weld. Similar to what was seen with robotic prostatectomy,
the advantages of robotics should shorten the learning
curve associated with minimally invasive cystectomy as
compared with standard laparoscopy, and should facilitate
performance of an adequate pelvic lymphadenectomy.
Skinner et al. reviewed existing data today on the impact
of surgical techniques on oncological outcomes. Its purpose
was to encourage the surgeon to focus on surgical tech-
nique and emphasized the commitment to achieving com-
plete surgical excision, minimizing local recurrence, and
maximizing the removal of potentially involved lymph
nodes [33]. The role of a regional lymphadenectomy in the
surgical management of high-grade invasive transitional
cell carcinoma of the bladder has evolved over the last sev-
eral decades and is now commonly accepted [34]. Pelvic
lymphadenectomy may provide a therapeutic beneWt in
addition to its prognostic information. Although, the abso-
lute limits of the lymphadenectomy remain a subject of
controversy, with no level I evidence, it is generally agreed
that adequate lymph node dissection should extend up to or
beyond the hypogastric artery and include the nodal packets
medial to and below the obturator nerve [35], and that the
extent of the PLND correlates with survival advantage [36].
Poulsen et al. [8] retrospectively compared extended pelvic
lymphadenectomy (proximally to the aortic bifurcation)
with limited dissection (proximally to the common iliac) at
the time of open radical cystectomy, and found a statisti-
cally signiWcant though small improvement in Wve-year
recurrence-free survival for the extended dissection group
(62 vs. 56% limited dissection) and a substantial improve-
ment (85 vs. 64%) for the subgroups with tumors conWned
to the bladder wall (tumor stage pT3a or less) [8]. The
Bladder Cancer Collaborative Group proposed guidelines
for the surgical management of bladder. At least 10–14
lymph nodes should be retrieved at cystectomy, with a mar-
gin positive rate of less than 10% of all cases performed
(less than 15% for bulky tumors and less than 20% for
salvage cases) [37].
Pelvic lymph node dissection requires an additional 30–
60 min to the operative time, but no signiWcant diVerence in
perioperative mortality, early complications, or need for
blood transfusions [6, 8]. Since instituting titanium clips to
secure all lymphatics, we have not had any lymphoceles. A
survival advantage may result from a more complete exci-
sion of tissue harboring subclinical micrometastasis, as sup-
ported by polymerase chain reaction analysis revealing
bladder cancer-associated DNA in the lymph nodes of 29–
33% of patients classiWed as having node-negative disease
by standard histopathology [38, 39]. Recently, lymph node
density, even in the presence of positive lymph nodes,
oVers further prognostic value in predicting disease-speciWc
survival [40]. Our results demonstrated an acceptable num-
ber of harvested lymph nodes and risk of positive surgical
margins supporting our comparable assumption that onco-
logic standards for radical cystectomy can be maintained
with RARC. These results conWrm the technical feasibility
of a robot-assisted cystectomy in the performance of a pel-
vic lymphadenectomy with a single surgical assistant using
a six-port conWguration.
In addition, the objective of performing minimally inva-
sive surgery is to maintain comparable outcome while min-
imizing complications. As experience increases, further
improvements in clinicopathologic and functional outcome
can be achieved, as shown by the Badani et al. [41] after
performing 2,776 cases of robotic radical prostatectomy.
As more patients elect for minimally invasive procedures
over conventional open surgery, we believe that experience
with RARC may further improve clinical outcomes.123
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An acceptable PLND can be performed safely with robot
assistance, with outcome comparable with that achieved
with the open approach. These data support the continued
evaluation of RARC as a less invasive surgical approach to
management of invasive bladder cancer. The oncologic
eYcacy needs to be determined in a much larger study with
longer follow up. The perioperative outcomes were likewise
comparable with that of the gold standard, open cystectomy.
With experience, the extirpative time was observed to
decrease.
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